This post has been archived and contains information that may be out of date.
CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of the proposed remedy issued by the Centers for Medicare & Medicaid Services (CMS) for its 340B-acquired drug payment policy that was in effect from 2018-2022 for hospitals paid under the outpatient prospective payment system. The proposal is in response to a remand from the U.S. District Court for the District of Columbia and the U.S. Supreme Court’s decision in American Hospital Association v. Becerra.
This content is restricted to members.
